| SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans PA Mudd, AA Minervina, MV Pogorelyy, JS Turner, W Kim, E Kalaidina, ... Cell 185 (4), 603-613. e15, 2022 | 207 | 2022 |
| A multinational trial of prasugrel for sickle cell vaso-occlusive events MM Heeney, CC Hoppe, MR Abboud, B Inusa, J Kanter, B Ogutu, ... New England Journal of Medicine 374 (7), 625-635, 2016 | 146 | 2016 |
| Host predictors of broadly cross-reactive antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern differ between infection and … L Tang, S Cherry, EI Tuomanen, E Kirkpatrick Roubidoux, CY Lin, ... Clinical Infectious Diseases 75 (1), e705-e714, 2022 | 144* | 2022 |
| A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy JH Estepp, MP Smeltzer, G Kang, C Li, WC Wang, C Abrams, B Aygun, ... American journal of hematology 92 (12), 1333-1339, 2017 | 100 | 2017 |
| Pharmacogenetics for safe codeine use in sickle cell disease RS Gammal, KR Crews, CE Haidar, JM Hoffman, DK Baker, PJ Barker, ... Pediatrics 138 (1), 2016 | 83 | 2016 |
| Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response CY Lin, J Wolf, DC Brice, Y Sun, M Locke, S Cherry, AH Castellaw, ... Cell host & microbe 30 (1), 83-96. e4, 2022 | 76 | 2022 |
| Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood JS Hankins, JH Estepp, JR Hodges, MA Villavicencio, LL Robison, ... Pediatric blood & cancer 65 (9), e27228, 2018 | 68 | 2018 |
| Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia JH Estepp, B Winter, M Johnson, MP Smeltzer, SC Howard, JS Hankins Pediatric blood & cancer 61 (11), 2031-2036, 2014 | 62 | 2014 |
| Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children JH Estepp, MP Smeltzer, WC Wang, ME Hoehn, JS Hankins, B Aygun British journal of haematology 161 (3), 402-405, 2013 | 52 | 2013 |
| Development of the incharge health mobile app to improve adherence to hydroxyurea in patients with sickle cell disease: user-centered design approach NM Alberts, SM Badawy, J Hodges, JH Estepp, C Nwosu, H Khan, ... JMIR mHealth and uHealth 8 (5), e14884, 2020 | 45 | 2020 |
| Keeling's fetal and neonatal pathology TY Khong, RDG Malcomson Springer International Publishing, 2015 | 37 | 2015 |
| Sickle cell anemia: From basic science to clinical practice FF Costa, N Conran Springer, 2016 | 36* | 2016 |
| Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life RS Zahr, E Rampersaud, G Kang, MJ Weiss, G Wu, RL Davis, JS Hankins, ... Haematologica 104 (9), e385, 2019 | 34 | 2019 |
| Genetic variants associated with therapy-related cardiomyopathy among childhood cancer survivors of African ancestry Y Sapkota, N Qin, MJ Ehrhardt, Z Wang, Y Chen, CL Wilson, J Estepp, ... Cancer research 81 (9), 2556-2565, 2021 | 32 | 2021 |
| Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years JH Estepp, R Kalpatthi, G Woods, S Trompeter, RI Liem, K Sims, A Inati, ... Pediatric blood & cancer 69 (8), e29716, 2022 | 31 | 2022 |
| Voxelotor (GBT 440), a first‐in‐class hemoglobin oxygen‐affinity modulator, has promising and reassuring preclinical and clinical data JH Estepp American Journal of Hematology 93 (3), 326-329, 2018 | 26 | 2018 |
| The Edoxaban Hokusai VTE PEDIATRICS Study: An open‐label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease CH van Ommen, M Albisetti, AK Chan, J Estepp, J Jaffray, G Kenet, ... Research and practice in thrombosis and haemostasis 4 (5), 886-892, 2020 | 24 | 2020 |
| Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia JH Estepp, C Melloni, CD Thornburg, P Wiczling, Z Rogers, JA Rothman, ... The Journal of Clinical Pharmacology 56 (3), 298-306, 2016 | 24 | 2016 |
| Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia RS Zahr, JS Hankins, G Kang, C Li, WC Wang, J Lebensburger, ... American journal of hematology 94 (1), E27, 2019 | 23 | 2019 |
| Convergent epitope-specific T cell responses after SARS-CoV-2 infection and vaccination AA Minervina, MV Pogorelyy, AM Kirk, EK Allen, KJ Allison, CY Lin, ... MedRxiv, 2021.07. 12.21260227, 2021 | 21 | 2021 |
Jane S. HankinsSt. Jude Children's Research Hospital在 stjude.org 的电子邮件经过验证
